Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
34
# OF OVERLAPPING
HOLDINGS
XBI
137
HOLDINGS
26%
ALSO IN CANC
CANC
54
HOLDINGS
62%
ALSO IN XBI
SECTOR DRIFT (XBI minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ARCELLX, INC. | 1.6% | 3.4% | 1.6% |
|
REVOLUTION MEDICINES, INC. | 1.6% | 6.3% | 1.6% |
|
AMGEN INC | 1.5% | 2.5% | 1.5% |
|
CELCUITY INC. | 1.3% | 2.5% | 1.3% |
|
HALOZYME THERAPEUTICS INC | 1.3% | 1.3% | 1.3% |
XBI Overweight Relative to CANC
|
MODERNA, INC. | 2.2% |
 |
ROIVANT SCIENCES LTD. | 1.7% |
|
VAXCYTE, INC. | 1.7% |
|
AMICUS THERAPEUTICS INC | 1.5% |
|
MIRUM PHARMACEUTICALS, INC. | 1.4% |
|
KRYSTAL BIOTECH, INC. | 1.4% |
|
BIOMARIN PHARMACEUTICAL INC | 1.4% |
|
VERTEX PHARMACEUTICALS INC | 1.3% |
|
BIOGEN IDEC INC | 1.3% |
|
INCYTE CORP | 1.3% |
XBI Underweight Relative to CANC
 |
NOVARTIS AG | -4.9% |
|
REVOLUTION MEDICINES, INC. | -4.7% |
|
ASTRAZENECA PLC | -4.6% |
|
ELI LILLY & CO | -4.3% |
|
BRISTOL-MYERS SQUIBB CO | -4.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
|
MERCK & CO. INC. | -3.8% |
|
BRIDGEBIO PHARMA, INC. | -3.7% |
 |
GENMAB A/S SPONSORED ADR | -3.1% |
|
JOHNSON & JOHNSON | -2.5% |